Counter Cyclical Investments Crosses 5% Stake in Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Ltd 路 Acquisition/ Disposal of Shares 路 12 Oct 2026, 11:11 pm
Counter Cyclical Investments Crosses 5% Stake in Jenburkt Pharmaceuticals Counter Cyclical Investments Private Limited acquired 326 equity shares (0.01% stake) in Jenburkt Pharmaceuticals Ltd via an open-market transaction on 9th Oct'26. Following this acquisition on behalf of its PMS clients, the acquirer's aggregate holding increased from 2,20,605 shares (4.99%) to 2,20,931 shares, crossing the statutory 5% threshold to reach 5.01% of the company's total paid-up equity share capital of 44,13,300 shares. Consequently, disclosures were submitted under Regulation 29(1) of SEBI SAST Regulations, 2011.
Original exchange filing (PDF)
More announcements from Jenburkt Pharmaceuticals Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd 路 04 Nov 2026
- Outcome of the Board Meeting held today on 03rd November, 2026. 路 03 Nov 2026
- Standalone Unaudited Financial Results for the quarter and half year ended on 30th September, 2026. 路 03 Nov 2026
- Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Standalone Unaudited .... 路 03 Nov 2026
- Intimation regarding admission of Equity shares of the Company under " Permitted to trade" category on National Stock Exchange of India Limited. 路 22 Sept 2026
- Intimation about Resignation of a Senior Management Personnel of the Company. 路 18 Sept 2026
- Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April, 2027 to 31st March, 2032, Approved with requisite .... 路 05 Sept 2026
- Submission of consolidated Voting Results and Scrutinizer''s Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September, 2026. 路 05 Sept 2026
